KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Twist Bioscience (TWST) Tax Provisions (2017 - 2026)

Twist Bioscience has reported Tax Provisions over the past 10 years, most recently at $43000.0 for Q1 2026.

  • Quarterly Tax Provisions fell 78.5% to $43000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $734000.0 through Mar 2026, up 83.5% year-over-year, with the annual reading at $700000.0 for FY2025, 16.67% up from the prior year.
  • Tax Provisions was $43000.0 for Q1 2026 at Twist Bioscience, down from $253000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $700000.0 in Q1 2023 and troughed at -$222000.0 in Q3 2023.
  • The 5-year median for Tax Provisions is $200000.0 (2024), against an average of $163529.4.
  • Year-over-year, Tax Provisions tumbled 344.26% in 2022 and then skyrocketed 569.8% in 2023.
  • A 5-year view of Tax Provisions shows it stood at $76000.0 in 2022, then soared by 57.89% to $120000.0 in 2023, then decreased by 16.67% to $100000.0 in 2024, then skyrocketed by 153.0% to $253000.0 in 2025, then plummeted by 83.0% to $43000.0 in 2026.
  • Per Business Quant, the three most recent readings for TWST's Tax Provisions are $43000.0 (Q1 2026), $253000.0 (Q4 2025), and $238000.0 (Q3 2025).